Evidence mapPaperPMID 41607765Full record

ReviewWorld journal of gastrointestinal oncology2026

Tumor microenvironment-driven microRNA dysregulation: Key interactions in colorectal cancer progression.

Adriana G Quiroz-Reyes, Paulina Delgado-Gonzalez, Jose Francisco Islas, Veronica L Loaiza-Gutierrez, Michelle G Santoyo-Suarez, Juan A Garcia-Loredo, Carlos A Gonzalez-Villarreal, Fernanda Ramirez-Fernandez, Elsa N Garza-Treviño

Abstract readReview
In one paragraph

Review in World journal of gastrointestinal oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adriana G Quiroz-ReyesDepartment of Biochemistry and Molecular Medicine, Universidad Autonoma de Nuevo Leon, Monterrey 64460, Nuevo Leon, Mexico.
Paulina Delgado-GonzalezDepartment of Biochemistry and Molecular Medicine, Universidad Autonoma de Nuevo Leon, Monterrey 64460, Nuevo Leon, Mexico.
Jose Francisco IslasDepartment of Biochemistry and Molecular Medicine, Universidad Autonoma de Nuevo Leon, Monterrey 64460, Nuevo Leon, Mexico.
Veronica L Loaiza-GutierrezDepartment of Biochemistry and Molecular Medicine, Universidad Autonoma de Nuevo Leon, Monterrey 64460, Nuevo Leon, Mexico.
Michelle G Santoyo-SuarezDepartment of Biochemistry and Molecular Medicine, Universidad Autonoma de Nuevo Leon, Monterrey 64460, Nuevo Leon, Mexico.
Juan A Garcia-LoredoDepartment of Biochemistry and Molecular Medicine, Universidad Autonoma de Nuevo Leon, Monterrey 64460, Nuevo Leon, Mexico.
Carlos A Gonzalez-VillarrealUniversidad de Monterrey, UDEM Vicerrectoria de Ciencias de la Salud, Monterrey 66238, Nuevo Leon, Mexico.
Fernanda Ramirez-FernandezDepartment of Biochemistry and Molecular Medicine, Universidad Autonoma de Nuevo Leon, Monterrey 64460, Nuevo Leon, Mexico.
Elsa N Garza-TreviñoDepartment of Biochemistry and Molecular Medicine, Universidad Autonoma de Nuevo Leon, Monterrey 64460, Nuevo Leon, Mexico. elsa.garzatr@uanl.edu.mx.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer remains one of the leading causes of morbidity and mortality worldwide. Despite notable advances in early detection and therapeutic strategies, the molecular mechanisms underlying tumor survival, chemotherapy resistance, and metastasis are not yet fully understood. MicroRNAs (miRNAs) have emerged as pivotal regulators of cancer development, as they modulate gene expression and orchestrate key signaling pathways. However, the epigenetic mechanisms that control miRNA expression and their downstream gene targets remain largely unclear. In this review, we highlight the critical role of the colorectal cancer microenvironment in influencing miRNA expression and discuss how this regulation contributes to tumorigenesis. A better understanding of these processes may lead to the identification of novel therapeutic targets and strategies to prevent recurrence.

Indexed as

Cancer progressionColorectal cancerMicroRNAsTherapeutic responseTumor microenvironment

Identifiers

PMID41607765
PMCPMC12836183

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.